Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2020 to 2025) - by Type, End-user and Geography
DUBLIN, July 21, 2021 /PRNewswire/ -- The "Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2020-2025) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is estimated to be $21.4 billion in 2020 and is expected to reach $26.67 billion by 2025, growing at a CAGR of 4.5%.
Key factors, such as the rising prevalence of patients suffering from irregular heart rate and rhythm disorder, unhealthy diet habits & changing lifestyle, increasing healthcare expenditure, are likely to contribute to the growth of the market. Technological advancements in the field of CM and CRM devices are bolstering the market growth for CM & CRM Management. The introduction of advanced cardiac devices such as subcutaneous ICDs, Automated External Defibrillators (AEDs), and MRI pacemakers is also expected to propel the market growth.
However, the factor such as high treatment cost and high cost of CM & CRM devices hinders market growth. Also, the unfavorable reimbursement policies are impeding the market growth. The strict regulatory requirements and lack of technical expertise in operating Electrocardiography and CRM devices are a challenge for the market's growth.
The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is segmented further based on Type, End-User, and Geography.
By Type, the market for Cardiac Monitoring Management Devices is classified as ECG Devices, Event Monitors, and Smart ECG Monitors. Amongst all, the ECG Devices segment is estimated to hold the highest market share.
By Type, the Cardiac Rhythm Management Devices Market is segmented as defibrillators and pacemakers. Defibrillators is estimated to hold the highest market share during the forecast period.
By End-user, the market is classified as Hospitals; Clinics, Cardiac Centres, and Ambulatory Surgery Centres (ASCs); and Other End Users. Hospital segment holds the highest market share.
By Geography, North America accounted for the dominant share of the market.
1. Royal Philips, a global leader in health technology, announced that it had completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring - 9th February 2021
2. Abbott introduces Next-Generation Heart Rhythm Management Devices in Europe, featuring State-Of-The-Art Patient App and Bluetooth Connectivity - 18th February 2020
Some of the companies covered in this report are Medtronic plc, Koninklijke Philips N.V, GE Healthcare, Abbott Laboratories, BTL, BPL Medical Technologies, Boston Scientific Corporation, Hill Rom Holdings Inc, ACS Diagnostics, Biotronik, etc.
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments and growth in market share.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
- The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using a Competitive Quadrant, the analyst's proprietary competitive positioning tool.
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
184.108.40.206 Increasing Prevalence of Patients Suffering from Irregular Heart Rate and Rhythm Disorder
220.127.116.11 Increasing Investments and Expenditure in Healthcare Sector
18.104.22.168 Significant R&D Contributions from Leading Biotech Firms
22.214.171.124 Technological Advancements in CM & CRM techniques
126.96.36.199 The High Cost of CM & CRM Devices
188.8.131.52 Unfavourable Reimbursement Policies for CM & CRM devices
184.108.40.206 Measures to Reduce Infections Caused due to CIEDs
220.127.116.11 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
18.104.22.168 Lack of Technical Expertise in Operating Electrocardiography and Cardiac Rhythm Management Devices
22.214.171.124 Preference for Drugs over Expensive CM & CRM Devices
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Cardiac Monitoring Management Market, By Type
6.2 ECG Devices
6.2.1 Resting ECG Devices
6.2.2 Stress ECG Devices
6.2.3 Holter Monitors
6.3 Implantable Loop Recorders
6.4 Mobile Cardiac Telemetry Devices
6.5 Cardiac Output Monitoring Devices
6.6 Event Monitors
6.6.1 By Type
126.96.36.199 Pre-symptom Event Monitors
188.8.131.52 Post-Symptom Event Monitors
6.6.2 By Technology
184.108.40.206 Autodetect Monitors
220.127.116.11 Manual Event Monitors
6.7 Smart ECG Monitors
7 Global Cardiac Rhythm Management Market, By Type
7.2.1 Implantable Cardioverter Defibrillators
18.104.22.168 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
22.214.171.124.1 Biventricular ICDS/CRT-Ds
126.96.36.199.2 Dual-chamber ICDs
188.8.131.52.3 Single-chamber ICDs
184.108.40.206 Subcutaneous Implantable Cardioverter Defibrillators
7.2.2 External Defibrillators
220.127.116.11 Automated External Defibrillators
18.104.22.168.1 Semi-Automated External Defibrillators
22.214.171.124.2 Fully Automated External Defibrillators
126.96.36.199 Manual External Defibrillators
188.8.131.52 Wearable Cardioverter Defibrillators
7.3.1 By Implantability
184.108.40.206 Implantable Pacemakers
220.127.116.11 External Pacemakers
7.3.2 By Type
18.104.22.168 Dual-chamber pacemakers
22.214.171.124 Single-chamber pacemakers
126.96.36.199 Biventricular/CRT pacemakers
8 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By End User
8.3 Clinics, Cardiac Centres, and Ambulatory Surgery Centres
8.4 Other End Users
9 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By Geography
10 Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Mergers & Acquisitions
10.3.2 Agreement, Collaborations, & Partnerships
10.3.3 New Product Launches & Enhancements
10.3.4 Investments & funding
11 Company Profiles
11.1 Abbott Laboratories
11.2 Medtronic Plc
11.3 Boston Scientific Corporation
11.4 GE Healthcare
11.5 Koninklijke Philips N.V.
11.7 Asahi Kasei Corporation
11.8 Microport Scientific Corporation
11.9 Hill-Rom Holdings, Inc.
11.10 Nihon Kohden Corporation
11.11 Schiller AG
11.12 ACS Diagnostics
11.13 BPL Medical Technologies
11.15 Shenzhen Mindray Bio-Medical Electronics
11.16 Lepu Medical Technology
11.17 Shree Pacetronix
11.18 Osypka AG
11.19 Alivecor, Inc.
11.21 Bexen Cardio
11.22 Narang Medical Limited
11.23 Metrax GmbH
11.24 LivaNova plc
11.25 Cardiac Science Corporation (ZOLL Medical Corporation)
11.26 Jarvik Hearth. Inc
11.27 Berlin Hearth
11.28 Nihon Kohden Corporation
11.29 Progetti SRL
For more information about this report visit https://www.researchandmarkets.com/r/aiyjvc
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Upcoming Life Sciences Events
- August 2021
- Biotechgate Digital Partnering
- September 2021
- Swiss Biotech Day 2021
- Digital RESI